News from the healthcare data industry
Research to focus on gene at “heart” of Timothy Syndrome LONDON, ON, March 24, 2022 /PRNewswire/ — Timothy Syndrome Alliance (TSA) is creating a patient registry for the CACNA1C gene, which encodes the alpha-1-subunit of a voltage-dependent L-type calcium channel highly expressed in the heart and brain. To better understand the impact…
Pharma trailblazer will accelerate growth at COTA with a focus on advancing real-world data use in drug development, increasing diversity in clinical trials, and supporting the move to data-driven, value-based cancer care NEW YORK, March 24, 2022 /PRNewswire/ — COTA, Inc., an oncology real-world data and analytics company, announced today that Miruna Sasu, Ph.D.,…
Abstract Background: Clinical trials have shown immunotherapy (IO) to be more effective than chemotherapy in pre-treated, advanced non-small cell lung cancer (NSCLC). However, there is a lack of understanding of its effectiveness in clinical practice, and among patient groups that are often underrepresented in trials. We aimed to summarize the existing…
Lugano, Switzerland, 23 March 2022 – More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC) undergo biomarker testing, and this figure has increased over the last five years, reveal real-world data from a Spanish national registry study reported at the European Lung Cancer Congress (ELCC), 30 March-2 April 2022….
Leveraging The Syapse Learning Health Network, and real-world data platform, Main Line Health will optimize its ability to match patients March 22, 2022 10:00 ET | Source: Syapse SAN FRANCISCO, March 22, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by…
Abstract Aims: Using German claims, the authors replicated the CHAARTED trial in metastatic hormone-sensitive prostate cancer. Methods: The authors identified metastatic hormone-sensitive prostate cancer patients replicating the inclusion/exclusion criteria of CHAARTED. Patients treated with docetaxel in combination with androgen deprivation therapy (ADT) at first line (docetaxel group) were compared with patients treated with…
22 Mar 2022 Francesca Bruce@ScripFrancesca Francesca.bruce@informa.com Executive Summary England’s health technology appraisal body, NICE, will publish a framework that will help it deliver on its ambition to use real-world evidence to close knowledge gaps and improve technology evaluations.Source: Alamy NICE, the health technology appraisal institute for England and Wales, is preparing…
March 21, 2022 09:58 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced the launch of EDGE, an innovative platform that allows pathologists to access developing AI models intended to identify specimens with potentially actionable biomarkers using a single hematoxylin and eosin stain…
As the industry begins to embrace the power of AI, the lakehouse brings patient, research, and operational data together at scale to deliver new innovations in research and care SAN FRANCISCO, March 9, 2022 /PRNewswire/ — Databricks, the Data and AI company and pioneer of the data lakehouse paradigm, today launched the…
Clarify announced the launch of Clarify Trials today. It is a real-world evidence-based software product thatempowers life sciences companies to improve the recruitment of diverse and underrepresented patient populations.This cloud software accelerates clinical trial recruitment within underrepresented communities and provides over 400 social determinants of health (SDoH) insights to identify research sites…